Vaccitech has established partnerships with leading institutions across the globe to support the development of its programs. Hover over the logos below for more information.
Vaccitech has entered into non-exclusive licensure of its T cell induction platform in oncology, and is committed to advancing the use of its platform for oncology in combination with checkpoint inhibitors.
To contact us about partnering, please email email@example.com
Ludwig Cancer Research is an international community of distinguished scientists dedicated to preventing and controlling cancer. American businessman Daniel K. Ludwig began to support cancer research with the establishment of the Ludwig Institute for Cancer Research in 1971. Today, the scientific efforts endowed through his resources have grown to encompass the Ludwig Institute and the Ludwig Centers and professorships at six U.S. institutions.